Project overview
The multipartner, multidisciplinary project OLIGOMED addresses urgent needs in healthcare, in particular cancer, Huntington's Disease and cardiovascular diseases.
We apply cutting edge oligonucleotide technology to find innovative solutions and create a novel platform for personalised medicine.
The project will deliver:
- highly skilled scientific staff required to fully exploit ON therapeutics for personalised medicine
- top-class training in organic and chemoenzymatic synthesis, ON analysis, and biomedical/medicinal testing
- transferable skills courses, specific industry relevant workshops and public engagement activities
?This combination makes OLIGOMED a truly exciting programme for Early Stage Researchers (ESRs). The platform will immediately benefit to both European citizens and commercial partners.?
In the long term, OLIGOMED`s flexible platform technology will be taken forward by our private sector and research institutions for exploitation and will thus strengthen the European innovation capacity in the field of ON therapies.
Read more about Oligonucleotide Therapeutics project.
